LB Pharmaceuticals Inc (LBRX)

NASDAQ

$30.90

LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. The company is headquartered in New York, New York.

Website: https://lbpharma.us

Sector:

Healthcare

Industry:

Biotechnology

68 analysts

Buy

Target: $45 (+45.63%)

Market Cap

$922M

Free Cash Flow Yield

-10.46%

Beta (5Y)

0.58

Price Chart

Adjust inflation

Log

Valuation

Market Cap$922M

P/B2.42

Profitability

EBITDA-$39M

EPS-$1.00

Financial Health

Free Cash Flow Yield-10.46%

Growth & Risk

Beta (5Y)0.58

Sharpe Ratio1.35